United States · Series B startup
10 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow DNAtriX and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$40Mraised across 10 rounds since 2006, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $13M sold, first sale Oct 2014
From a historical funding recordSEC filing: $1.5M sold, first sale Oct 2013
From a historical funding recordSEC filing: $1.5M sold, first sale Oct 2013
No investor was named in the report.
Reported by sec.govSEC filing: $886K sold, first sale Jul 2012
From the SEC filings it signed: 2 on the team.
On the board, as filediDaniel WatkinsDrew Patrick PardollFrancis Patrick McCormickIsaac Patrick Cheng
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Mercury Fund
Morningside Group
Targeted Technology Fund
Texas HALO Fund
Cancer Prevention and Research Institute of TexasMissing a round, or an investor who was in one? Tell us.
DNAtriX's investors include Mercury Fund, Morningside Group, Targeted Technology Fund, Texas HALO Fund and Cancer Prevention and Research Institute of Texas.
DNAtriX has raised $40M across 10 rounds since 2006.
DNAtriX's most recent round was a Series B of $20M in Oct 2014.
Its most recent round, $20M in Oct 2014, is also its largest on record.
DNAtriX's first round on record, in May 2006, was backed by Mercury Fund.
DNAtriX's latest named round is a Series B, in Oct 2014.
DNAtriX is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
